Log in to save to my catalogue

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopath...

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopath...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5698362

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome

About this item

Full title

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome

Publisher

Tokyo: Springer Japan

Journal title

Clinical and experimental nephrology, 2017-12, Vol.21 (6), p.961-970

Language

English

Formats

Publication information

Publisher

Tokyo: Springer Japan

More information

Scope and Contents

Contents

Background
We designed a prospective and randomized trial of mizoribine (MZR) therapy combined with prednisolone (PSL) for idiopathic membranous nephropathy (IMN) with steroid-resistant nephrotic syndrome (SRNS).
Methods
Patients with IMN were divided into 2 groups, and MZR combined with PSL was administered for 2 years. PSL was initially...

Alternative Titles

Full title

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5698362

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5698362

Other Identifiers

ISSN

1342-1751

E-ISSN

1437-7799

DOI

10.1007/s10157-016-1340-2

How to access this item